4657 related articles for article (PubMed ID: 9164512)
1. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
2. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL
Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
[TBL] [Abstract][Full Text] [Related]
4. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M
Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune hepatitis and/or hepatitis C].
Simonović J; Dokić Lj; Svirtlih N; Djordjević M; Bozić N; Poluga J
Srp Arh Celok Lek; 1999; 127(3-4):109-13. PubMed ID: 10500434
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
8. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
11. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
[TBL] [Abstract][Full Text] [Related]
13. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
[TBL] [Abstract][Full Text] [Related]
16. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.
Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH
Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
18. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
19. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
20. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
